NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE7579 Query DataSets for GSE7579
Status Public on Jul 31, 2008
Title GAR22: A novel target gene of thyroid hormone receptor causes growth inhibition in human erythroid cells
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Objective: Thyroid hormone receptors (TRs) are ligand-dependent transcription factors with a major impact on erythroid cell development. Here we investigated TR activity on red cell gene expression and identified TR target genes. The impact of the TR target gene GAR22 (growth arrest specific 2 [GAS2]-related gene on chromosome 22) on red cell differentiation was determined.
Methods: SCF/Epo dependent red cell progenitors were differentiated in vitro in the presence or absence of thyroid hormone. Hormone-induced changes in gene expression were measured by a genome-wide approach with DNA microarrays. Ectopic expression of the TR target gene GAR22 was used to determine its impact on red cell differentiation.
Results: Ligand-activated TR effectively accelerated red cell progenitor differentiation in-vitro concomitantly with inducing growth arrest. We demonstrate that activated TR induced specific gene expression patterns of up- or down-regulated genes, including distinct clusters associated with accelerated differentiation in response to treatment. Mining for T3 induced genes identified BTEB1 (basic transcription element binding protein 1/Krüppel-like factor 9) and GAR22 as TR target genes. BTEB1/KLF9 is a known TR target gene while GAR22, initially identified as a putative tumor suppressor, represents a novel TR target gene. We demonstrate that ectopic GAR22 expression in red cell progenitors lengthens the cell cycle and causes growth inhibition, but leaves red cell gene expression unaffected.
Conclusion: This study identifies GAR22 as a novel and direct TR target gene. Our results suggest that hormone-induced GAR22 might represent an important trigger of growth inhibition induced by thyroid hormone in red cell progenitors.
 
Overall design 13 hybridizations in two individual experiments.
Experiment 1:
1_SCF/Epo, 1_Epo/insulin(8h), 1_Epo/insulin(24h), 1_Epo/insulin(48h)
Experiment 2:
2_SCF/Epo, 2_Epo/insulin(8h), 2_Epo/insulin(24h), 2_Epo/insulin(48h)
2_Epo/insulin+T3(8h), 2_Epo/insulin+9cRA(8h)
2_Epo/insulin+T3+9cRA(8h), , 2_Epo/insulin+T3+9cRA(24h), 2_Epo/insulin+T3+9cRA(48h)
 
Contributor(s) Gamper I, Koh K, Ruau D, Ullrich K, Bartunkova J, Hacker C, Bartunek P, Zenke M
Citation(s) 19375645
Submission date Apr 23, 2007
Last update date Dec 13, 2018
Contact name Martin Zenke
E-mail(s) Martin.Zenke@rwth-aachen.de
Phone +49-241-80 80760
Organization name Institute for Biomedical Engineering
Department Cell Biology
Street address Universitatsklinikum Aachen, RWTH
City Aachen
State/province NRW
ZIP/Postal code 52074
Country Germany
 
Platforms (1)
GPL8300 [HG_U95Av2] Affymetrix Human Genome U95 Version 2 Array
Samples (13)
GSM179757 Erythroid progenitor cells. SCF+Epo cells 0hr 1.
GSM180044 Erythroid progenitor cells. SCF+Epo cells 0hr 2.
GSM180045 Erythroid progenitor cells. Epo+insulin cells 8hr 1.
Relations
BioProject PRJNA100321

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE7579_RAW.tar 110.5 Mb (http)(custom) TAR (of CEL, CHP, EXP)
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap